N/A N=1,105 Female Patient Preferences Regarding Physician Gender
Female Patient Preference
Primary: Proportion of Female Respondents Having Their Preferences Based on Physician Gender for the OB/GYN Care — 667; 87; 261 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=743 Treatment Preference and Patient Centered Prostate Cancer Care
Prostate Cancer
Primary: Change in Satisfaction With Care — 0.26; 0.07; 0.28; 0.06 units on a scale
N/A N=117 Patient Preferences for Leadless Pacemakers
Cardiac Rhythm Disorder · Bradycardia · Cardiac Pacemaker Artificial
Primary: Mean Rankings for Pacemaker Device Features — 2.3; 2.6; 2.2; 4.7 score on a scale
N/A N=154 Preference Tiotropium Respimat Study in COPD
Pulmonary Disease, Chronic Obstructive
Primary: Total Mean Score of the Validated Patient Satisfaction and Preference Questionnaire (PASAPQ) — 80.71; 79.92 units on a scale
Phase 4 N=377 Comparator Study Evaluating Patient Preference Of FFNS vs. FPNS
Rhinitis, Allergic, Perennial
Primary: Comparison of Mean Change From Baseline in Daily Reflective Total Nasal Symptom Score (rTNSS) Over Treatment Periods of Active Drug Nasal Sprays Versus Placebos — -2.7…
N/A N=136 Aspiring to Awesome- Patient Preference Privacy Selections in EMR
Sexually Transmitted Diseases
Primary: Number of Patients Recording Preferences to Restrict Provider Access to Some or All Electronic Health Record (EHR) Data — 45; 13 participants
N/A N=47,396 Aligning Patient Preferences: a Role Offering Alzheimer's Patients, Caregivers, and Healthcare Providers Education and Support
Alzheimer Disease · Dementia
Primary: Hospital Transfers — 1.2; 1.3 number of hospital transfers — p=0.3313
N/A N=1,103 Measuring the Preferences of Patients With Type II Diabetes Using Best-worst Scaling and Discrete Choice Experiment
Type II Diabetes
Primary: Patient Medication Preference as Estimated by a Choice Model — 0.983; 0.362; 0.284; 0.261 utility of
Phase 3 N=130 Study Evaluating Preference, Satisfaction and Ease of Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Diagnosed Patients
Chronic Obstructive Pulmonary Disease (COPD)
Primary: Percentage of Patients Who Prefer Genuair Device Versus Handihaler Device at Visit 2 — 68.6; 18.1; 13.3 Percentage of Patients
Phase 4 N=360 Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS
Rhinitis, Allergic, Perennial
Primary: Comparison of Mean Change From Baseline in Daily Reflective Total Nasal Symptom Score (rTNSS) Over Each Treatment Period of Active Drug Nasal Sprays Versus Placebos…
N/A N=51 Understanding What Matters Most to Patients: Establishing the Validity of a Best-Worst Scaling Survey
Hematologic Neoplasms
Primary: Content Validity of Best-Worst Scaling (BWS) Survey — 10; 0 Participants
N/A N=178 Patient Priorities Care Among Persons Living With Mild Cognitive Impairment and Dementia
Dementia · Mild Cognitive Impairment
Primary: Documentation of PPC Discussion — 72; 106 Participants
Phase 4 N=217 Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
Rheumatoid Arthritis · Plaque Psoriasis
Primary: Percentage of Participants With a Preference for Autoinjector A Versus Autoinjector B — 41.7; 43.5; 36.8 percentage of participants
N/A N=207 Considering Patient Diet Preferences to Optimize Weight Loss
Obesity
Primary: Percent Change in Body Weight From Baseline to 48 Weeks — -4.2; -5.3 percentage of weight change — p=<0.05
N/A N=1,103 Measuring the Priorities of Patients With Type II Diabetes Using Likert Scale and Best-worst Scaling
Type II Diabetes
Primary: Priority Scores for Potential Barriers and Facilitators for Diabetes Self-management — 0.505; 0.327; 0.500; 0.369 units on a scale
N/A N=264 Patient Priority Care for Older Adults With Multiple Chronic Conditions
Multiple Chronic Conditions
Primary: Treatment Burden — 11.9; 11.6; 12.7; 17.9 score on a scale
N/A N=346 Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer
Breast Cancer · Colorectal Cancer · Kidney Cancer
Primary: Priorities of Patients Receiving First Medical Treatment for Cancer at Treatment Initiation — 199; 93; 141; 80 Participants
N/A N=897 PREFER (Pacemaker Remote Follow-Up Evaluation and Review)
Bradycardia · Arrhythmia
Primary: Percentage of Participants With First Diagnosis of Clinically Actionable Events (CAE) at 12 Months — 35; 47 Percentage of participants — p=<0.0001
N/A N=17 IPG Replacement Study (PREFERENCE-H)
Parkinson Disease
Primary: The Percentage of Subjects Who Indicate Preference on Constant Current Over Constant Voltage at the 3 Month Follow-up Visit. — 4 participants
Phase 4 N=139 Study Evaluating Preference, Satisfaction And Correct Use Of Inhalers In COPD Patients
Chronic Obstructive Pulmonary Disease (COPD)
Primary: Number of Participants Who Correctly Used the Device at the Start of Handling the Device — 55; 49 Participants — p=0.451
Phase 3 N=168 Patient Preference Study of Pazopanib Versus Sunitinib in Advanced or Metastatic Kidney Cancer
Carcinoma, Renal Cell
Primary: Number of Participants With Preference for Pazopanib Versus Sunitinib as Assessed by the Patient Preference Questionnaire (PPQ) — 19; 6; 37; 43 participants — p=<0.001
Phase 4 N=405 Patient Preference and Satisfaction With Insulin Glargine (Lantus) Solostar Pen vs Conventional Vial-Syringe Method of Lantus Injection Therapy in Patients With Type 2 Diabetes Mellitus
Diabetes Mellitus, Type 2
Primary: Patient Overall Preference — 4.75; 2.45 units on a scale — p=<0.0001
N/A N=21 Patient Priorities Care for Hispanics With Dementia
Multiple Chronic Conditions · Dementia
Primary: Self-reported Perceived Value of Patient Priorities Care (PPC) Approach — 75; 85.7 percentage of participants
N/A N=161 Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP)
Type 1 Diabetes
Primary: Portion of Study Participants Reporting Greater Utility From AGP vs. Traditional Glucose Data Reports — 35; 29; 10 participants
N/A N=200 Intuition vs. Deliberation in Medical Decision Making
Decision Making About Life-sustaining Treatment in Patients With Serious Cardiac, Respiratory and Oncological Conditions Likely to Limit Life Expectancy
Primary: Acceptance or Refusal of a Feeding Tube for Chronic Aspiration — 41; 45; 56; 57 Participants
N/A N=750 Aligning Patients and Their Primary Care Providers
Primary Health Care · Quality of Health Care · Comorbidity
Primary: Aggregate Measure of Guideline-Based Clinical Care Gaps — 184; 210 Participants
Phase 4 N=88 Lung Function and Patient Preference With QVA149 vs. Tiotropium in COPD Patients
Chronic Obstructive Pulmonary Disease · COPD
Primary: Forced Expiratory Volume in One Second (FEV1) at 1 h Post-inhalation — 1.676; 1.595 Liters — p=0.0017
N/A N=550 Evaluating a Preference-based Intervention for Increasing Colorectal Cancer Screening
Colorectal Neoplasms
Primary: Colorectal Cancer (CRC) Screening Rate. — 40.1; 40.2; 19.3 percentage of participants
Phase 2 N=148 Open-label, Multicenter Study Assessing Preference for Deferasirox Film-coated Tablet Compared to Dispersible Tablet
Transfusion-dependent Thalassemia · Non-transfusion-dependent Thalassemia
Primary: Number of Participants Preferring Deferasirox FCT or DT at Week 48 Based on Preference Questionnaire (Item 2) — 10; 121; 3 Participants — p=<.0001
Phase 4 N=50 A Preference Study Comparing Kristalose® and Liquid Lactulose
Constipation
Primary: Patient Preference in Terms of Overall Preference and Preference of Taste, Consistency, and Portability. — 7; 6; 12; 11 participants